|
Market Closed -
Japan Exchange
07:30:00 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,356.50 JPY | +1.25% |
|
+1.27% | +12.59% |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| 08-06 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| Market Cap | 4,225B 26.55B 22.93B 21.55B 19.6B 36.85B 2,539B 37.46B 253B 98.73B 1,271B 99.69B 97.53B | P/E 2027 * |
11.4x | P/E 2028 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4,236B 26.62B 22.99B 21.61B 19.65B 36.94B 2,546B 37.55B 253B 98.99B 1,275B 99.95B 97.78B | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.78x |
| Free-Float |
98.88% | Yield 2027 * |
3.41% | Yield 2028 * | 3.52% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +1.25% | ||
| 1 week | +1.27% | ||
| Current month | +7.02% | ||
| 1 month | +9.81% | ||
| 3 months | -0.46% | ||
| 6 months | -6.13% | ||
| Current year | +12.59% |
| 1 week | 2,297 |  | 2,377 |
| 1 month | 2,125 | | 2,377 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 31/05/2019 |
| Director/Board Member | 58 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | +1.27% | +42.65% | +5.96% | 26.55B | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | |
| Average | -0.47% | +0.56% | +30.12% | +39.11% | 362.17B | |
| Weighted average by Cap. | -0.08% | +0.33% | +41.32% | +61.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,320B 14.58B 12.59B 11.83B 10.76B 20.23B 1,394B 20.56B 139B 54.21B 698B 54.73B 53.55B | 2,124B 13.35B 11.53B 10.83B 9.85B 18.53B 1,276B 18.83B 127B 49.64B 639B 50.12B 49.03B |
| Net income | 355B 2.23B 1.93B 1.81B 1.65B 3.1B 213B 3.15B 21.23B 8.3B 107B 8.38B 8.2B | 328B 2.06B 1.78B 1.67B 1.52B 2.86B 197B 2.91B 19.63B 7.67B 98.82B 7.75B 7.58B |
| Net Debt | 11.12B 69.9M 60.37M 56.73M 51.6M 97M 6.68B 98.6M 665M 260M 3.35B 262M 257M | -444B -2.79B -2.41B -2.27B -2.06B -3.88B -267B -3.94B -26.56B -10.38B -134B -10.48B -10.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | JP¥2,356.50 | +1.25% | 5,434,500 |
| 13/08/26 | JP¥2,327.50 | -1.21% | 4,696,600 |
| 12/08/26 | JP¥2,356.00 | -0.30% | 6,164,000 |
| 10/08/26 | JP¥2,363.00 | +1.55% | 6,287,500 |
| 07/08/26 | JP¥2,327.00 | +1.68% | 8,001,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
